Adjuvant radiotherapy in early stage ovarian carcinoma

International Journal of Oncology

Volumn 10, Issue 5, 1997, Pages 945-951

  Sorbe, Bengt ^a   Nordqvist, Sarah ^a  

^a ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

Author keywords

early stages; ovarian carcinoma; prognosis; radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; PLATINUM DERIVATIVE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CONTROLLED STUDY; EARLY CANCER; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030979496     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.10.5.945     Document Type: Article

References (26)

1. Benjamin I and Rubin SC: Management of early-stage epithelial ovarian cancer. Obstet Gynecol Clin N Amer 21: 107-119, 1994.
2. Soper JT: Management of early-stage epithelial ovarian cancer. Clin Obstet Gynecol 37: 423-438, 1994.
3. Gadducci A, Del Bravo B, Cardosi Carrara A, D'Amico M and Fioretti P: Adjuvant treatment of early stage ovarian carcinoma. Clin Exp Obstet Gynecol 17: 131-139, 1990.
4. Mackintosh J, Buckley CH, Tindall VR, Lind MJ, Anderson H and Crowther D: The role of postoperative alkylating agent therapy in early-stage epithelial ovarian cancer. Br J Obstet Gynaecol 96: 353-357, 1989.
5. Dottino PR, Plaxe SC and Cohen CJ: A phase II trial of adjuvant cisplatin and doxorubicin in stage 1 epithelial ovarian cancer. Gynecol Oncol 43: 203-205, 1991.
6. Wils J and van Geuns H: Chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide as an adjunct to surgery in stage IC-II epithelial ovarian carcinoma. Am J Clin Oncol 12: 251-254, 1989.
7. Klaassen D, Starreveld A, Shelly W, Miller A, Boyes D, Gerulath A and Levitt M: External beam pelvic radiotherapy plus intraperitoneal radioactive chromic phosphate in early stage ovarian cancer: a toxic combination. A National Cancer Institute of Canada Clinical Trials Group Report. Int J Radial Oncol Biol Phys 11: 1801-1804, 1985.
8. 32P) in women with early ovarian carcinoma after comprehensive surgical staging. Obstet Gynecol 79: 993-997, 1992.
9. Thomas GM: Radiotherapy in early ovarian cancer. Gynecol Oncol 55: 73-79, 1994.
10. Macbeth FR, Macdonald H and Williams CJ: Total abdominal and pelvic radiotherapy in the management of early stage ovarian carcinoma. Int J Radiat Oncol Biol Phys 15: 353-358, 1988.
11. Pietrzak K, Sablinska B and Zielinski J: Clinical analysis and evaluation of the results of adjuvant treatment (radiotherapy and chemotherapy) in ovarian carcinoma. Eur J Gynaecol Oncol 14 (Suppl.): 133-139, 1993.
12. Reinfuss M, Kojs Z and Skolyszewski J: External beam radiotherapy in the management of ovarian carcinoma. Radiother Oncol 26: 26-32, 1993.
13. Leers WH and Kock HC: The evaluation of postoperative irradiation in patients with early-stage ovarian cancer. Gynecol Oncol 28: 41-49, 1987.
14. Klaassen D, Shelley W, Starreveld A, Kirk M, Boycs D, Gerulath A, Levitt M, Fraser R, Carmichael J and Methot Y: Early stage ovarian cancer: a randomized clinical trial comparing whole abdominal radiotherapy, melphalan, and intraperitoneal chromic phosphate: a National Cancer Institute of Canada Clinical Trials Group report. J Clin Oncol 6: 1254-1263, 1988.
15. Krauss T, Meden H, Rath W and Kuhn W: Results of postoperative radiotherapy with iridium-192 in patients with ovarian cancer. ZBL Gynakol 114: 603-605, 1992.
16. Schueler JA, Cornelisse CJ, Hermans J, Trimbos JB, van der Burg ME and Fleuren GJ: Prognostic factors in well-differentiated early-stage epithelial ovarian cancer. Cancer 71: 787-795, 1993.
17. Young RC, Walton LA, Ellenberg SS, Homesley HD, Wilbanks GD, Decker DG, Miller A, Park R and Major F: Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials. N Engl J Med 322: 1021-1027, 1990.
18. Chiara S, Conte PF, Franzone P, Orsatti M, Bruzzone M, Rubagotti A, Odicino F, Rugiati S, Carnino F, Rosso R and Ragni N: High-risk early-stage ovarian cancer. Am J Clin Oncol 17: 72-76, 1994.
19. Young RC, Brady MF, Walton LA, Homesley HD, Averette HE and Long HJ: Localized ovarian cancer in the elderly. The Gynecologic Oncology Group experience. Cancer 71 (Suppl. 2): 601-605, 1993.
20. Malmström H, Simonsen E and Westberg R: A phase II study of intraperitoneal carboplatin as adjuvant treatment in early-stage ovarian cancer patients. Gynecol Oncol 52: 20-25, 1994.
21. McGowan L: Adjuvant intraperitoneal chromic phosphate therapy in a woman with early ovarian carcinoma and pelvic infection with resulting catastrophic complications. Clin Nucl Med 19: 696-698, 1994.
22. Vergote IB, Vergote-De Vos LN, Abeler VM, Aas M, Lindegaard MW, Kjorstad KE and Tropé CG: Randomized trial comparing cisplatin with radioactive phosphorus or wholeabdomen irradiation as adjuvant treatment of ovarian cancer. Cancer 69: 741-749, 1992.
23. Peters WA, Smith MR, Cain JM, Lee RB and Yon JL Jr: Intraperitoneal P-32 is not an effective consolidation therapy after a negative second-look laparotomy for epithelial carcinoma of the ovary. Gynecol Oncol 47: 146-149, 1992.
24. Goodman A, Bornstein L, Ball H, Smith DM and Bankoff M: Chromic phosphate therapy in carcinoma of the ovary. J Am Coll Surg 179: 401-406, 1994.
25. Colombo N, Chiari S, Maggioni A, Bocciolone L, Torn V and Mangioni C: Controversial issues in the management of early epithelial ovarian cancer: conservative surgery and role of adjuvant therapy. Gynecol Oncol 55: 47-51, 1994.
26. Withers HR, Peters LJ and Taylor JMG: Dose-response relationship for radiation therapy of subclinical disease. Int J Radiat Oncol Biol Phys 31: 353-359, 1995.